Revenue
8.63 million USD
2022 Q4 · USD
170 filing records in this dataset, filed from 2016-10-07 to 2023-04-28. Reported financial figures are available; chart coverage varies by period.
8.63 million USD
2022 Q4 · USD
-159.1%
2022 Q4 · %
-11.8 million USD
2022 Q4 · USD
30400000 USD
737000 USD
8626769 shares
56.67% · 3.12 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
103 million USD
2022-01-01 – 2022-12-31
-103 million USD
2022-01-01 – 2022-12-31
-64.3 million USD
2022-01-01 – 2022-12-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2023-04-28.
Financial data available through: 2022-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 95.37 million
–
Current period
USD 102.82 million
–
102821000 − 95369000 = 7452000 USD
95369000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source102821000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 199.77 million
–
Current period
−USD 103.43 million
–
-103427000 − -199768000 = 96341000 USD
-199768000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-103427000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 129.8 million
–
Current period
−USD 64.35 million
–
-64348000 − -129796000 = 65448000 USD
-129796000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-64348000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 474,000
–
Current period
USD 417,000
–
417000 − 474000 = -57000 USD
474000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source417000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | 13944000 | 64652000 Derived | -50708000 | -108000 Derived | -50600000 | -37066000 Derived | Source
|
| 2016 2016-01-01 – 2016-12-31 | 20551000 | 106298000 Derived | -85747000 | 1968000 Derived | -87715000 | -49357000 Derived | Source
|
| 2017 2017-01-01 – 2017-12-31 | 38043000 | 148031000 Derived | -109988000 | 21182000 Derived | -131170000 | -86952000 Derived | Source
|
| 2018 2018-01-01 – 2018-12-31 | 89100000 | 215918000 Derived | -126818000 | -9378000 Derived | -117440000 | -112708000 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 101229000 | 220272000 Derived | -119043000 | 4706000 Derived | -123749000 | -106695000 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 144391000 | 264118000 Derived | -119727000 | 26452000 Derived | -146179000 | -136380000 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 95369000 | 245801000 Derived | -150432000 | 49336000 Derived | -199768000 | -130270000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 102821000 | 172835000 Derived | -70014000 | 33413000 Derived | -103427000 | -64765000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Revenue | 13944000 |
|
| 2016 | Revenue | 20551000 |
|
| 2017 | Revenue | 38043000 |
|
| 2018 | Revenue | 89100000 |
|
| 2019 | Revenue | 101229000 |
|
| 2020 | Revenue | 144391000 |
|
| 2021 | Revenue | 95369000 |
|
| 2022 | Revenue | 102821000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Year over year | No prior comparable period |
|
| 2016 | Year over year | 47.4% |
|
| 2017 | Year over year | 85.1% |
|
| 2018 | Year over year | 134.2% |
|
| 2019 | Year over year | 13.6% |
|
| 2020 | Year over year | 42.6% |
|
| 2021 | Year over year | -34% |
|
| 2022 | Year over year | 7.8% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Operating margin | -363.7% |
|
| 2016 | Operating margin | -417.2% |
|
| 2017 | Operating margin | -289.1% |
|
| 2018 | Operating margin | -142.3% |
|
| 2019 | Operating margin | -117.6% |
|
| 2020 | Operating margin | -82.9% |
|
| 2021 | Operating margin | -157.7% |
|
| 2022 | Operating margin | -68.1% |
|
| 2015 | Net margin | -362.9% |
|
| 2016 | Net margin | -426.8% |
|
| 2017 | Net margin | -344.8% |
|
| 2018 | Net margin | -131.8% |
|
| 2019 | Net margin | -122.2% |
|
| 2020 | Net margin | -101.2% |
|
| 2021 | Net margin | -209.5% |
|
| 2022 | Net margin | -100.6% |
|
| 2015 | Free cash flow margin | -265.8% |
|
| 2016 | Free cash flow margin | -240.2% |
|
| 2017 | Free cash flow margin | -228.6% |
|
| 2018 | Free cash flow margin | -126.5% |
|
| 2019 | Free cash flow margin | -105.4% |
|
| 2020 | Free cash flow margin | -94.5% |
|
| 2021 | Free cash flow margin | -136.6% |
|
| 2022 | Free cash flow margin | -63% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Operating cash flow | -33756000 |
|
| 2016 | Operating cash flow | -47870000 |
|
| 2017 | Operating cash flow | -81512000 |
|
| 2018 | Operating cash flow | -109387000 |
|
| 2019 | Operating cash flow | -96981000 |
|
| 2020 | Operating cash flow | -127758000 |
|
| 2021 | Operating cash flow | -129796000 |
|
| 2022 | Operating cash flow | -64348000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2015 | Free cash flow | -37066000 |
|
| 2016 | Free cash flow | -49357000 |
|
| 2017 | Free cash flow | -86952000 |
|
| 2018 | Free cash flow | -112708000 |
|
| 2019 | Free cash flow | -106695000 |
|
| 2020 | Free cash flow | -136380000 |
|
| 2021 | Free cash flow | -130270000 |
|
| 2022 | Free cash flow | -64765000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Liabilities / assets | 18.6% |
|
| 2016 | Liabilities / assets | 67.3% |
|
| 2017 | Liabilities / assets | 35.4% |
|
| 2018 | Liabilities / assets | 44.3% |
|
| 2019 | Liabilities / assets | 43.3% |
|
| 2020 | Liabilities / assets | 57% |
|
| 2021 | Liabilities / assets | 87.1% |
|
| 2022 | Liabilities / assets | 111.9% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Current assets / current liabilities | 3.7× |
|
| 2016 | Current assets / current liabilities | 1.85× |
|
| 2017 | Current assets / current liabilities | 1.86× |
|
| 2018 | Current assets / current liabilities | 3.31× |
|
| 2019 | Current assets / current liabilities | 3.23× |
|
| 2020 | Current assets / current liabilities | 4.7× |
|
| 2021 | Current assets / current liabilities | 1.39× |
|
| 2022 | Current assets / current liabilities | 1.09× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | −USD 50.6 million Exact valueExact value: -50600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 33.76 million Exact valueExact value: -33756000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.31 million Exact valueExact value: 3310000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 37.07 million Calculation and evidence-33756000 − 3310000 USD Exact free cash flow: -37066000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2016 2016-01-01 – 2016-12-31 | −USD 87.72 million Exact valueExact value: -87715000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 47.87 million Exact valueExact value: -47870000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.49 million Exact valueExact value: 1487000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49.36 million Calculation and evidence-47870000 − 1487000 USD Exact free cash flow: -49357000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 131.17 million Exact valueExact value: -131170000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 81.51 million Exact valueExact value: -81512000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5.44 million Exact valueExact value: 5440000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 86.95 million Calculation and evidence-81512000 − 5440000 USD Exact free cash flow: -86952000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 117.44 million Exact valueExact value: -117440000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 109.39 million Exact valueExact value: -109387000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.32 million Exact valueExact value: 3321000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 112.71 million Calculation and evidence-109387000 − 3321000 USD Exact free cash flow: -112708000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 123.75 million Exact valueExact value: -123749000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 96.98 million Exact valueExact value: -96981000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 9.71 million Exact valueExact value: 9714000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 106.7 million Calculation and evidence-96981000 − 9714000 USD Exact free cash flow: -106695000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 146.18 million Exact valueExact value: -146179000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 127.76 million Exact valueExact value: -127758000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8.62 million Exact valueExact value: 8622000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 136.38 million Calculation and evidence-127758000 − 8622000 USD Exact free cash flow: -136380000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 199.77 million Exact valueExact value: -199768000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 129.8 million Exact valueExact value: -129796000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 474,000 Exact valueExact value: 474000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 130.27 million Calculation and evidence-129796000 − 474000 USD Exact free cash flow: -130270000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 103.43 million Exact valueExact value: -103427000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 64.35 million Exact valueExact value: -64348000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 417,000 Exact valueExact value: 417000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 64.77 million Calculation and evidence-64348000 − 417000 USD Exact free cash flow: -64765000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
170 filings · 5,106 latest values · 5,106 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001300699, 1300699, ATNX, edgar:1300699
Also known as ATHENEX, INC., Athenex, Inc., Kinex Pharmaceuticals LLC, Kinex Pharmaceuticals, Inc.